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Structural Evidence That Colicin A Protein Binds to a Novel
Binding Site of TolA Protein in Escherichia coli Periplasm*□S
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Background: Colicins interact with Tol proteins in the periplasm to facilitate their killing of E. coli cells.
Results: The N terminus of colicin A interacts with the C terminus of TolA through -strand addition.
Conclusion: Colicin A interacts with TolA at a novel binding site to promote cell killing.
Significance: TolA is integral to cell entry of colicin A, providing information to refine current models of colicin translocation.
TheTol assembly of proteins is an interacting network of pro-
teins located in theEscherichia coli cell envelope that transduces
energy and contributes to cell integrity. TolA is central to this
network linking the inner and outermembranes by interactions
with TolQ, TolR, TolB, and Pal. Group A colicins, such as ColA,
parasitize the Tol network through interactions with TolA
and/or TolB to facilitate translocation through the cell envelope
to reach their cytotoxic site of action. We have determined the
first structure of the C-terminal domain of TolA (TolAIII)
bound to anN-terminalColApolypeptide (TA53–107). The inter-
face region of the TA53–107-TolAIII complex consists of polar
contacts linking residues Arg-92 to Arg-96 of ColA with resi-
dues Leu-375–Pro-380 of TolA, which constitutes a -strand
addition commonly seen in more promiscuous protein-protein
contacts. The interface region also includes three cation-
interactions (Tyr-58–Lys-368, Tyr-90–Lys-379, Phe-94–Lys-
396), which have not been observed in any other colicin-Tol
protein complex. Mutagenesis of the interface residues of ColA
or TolA revealed that the effect on the interaction was cumula-
tive; single mutations of either partner had no effect on ColA
activity, whereas mutations of three or more residues signifi-
cantly reduced ColA activity. Mutagenesis of the aromatic ring
component of the cation- interacting residues showed Tyr-58
of ColA to be essential for the stability of complex formation.
TA53–107 binds on the opposite side of TolAIII to that used by
g3p, ColN, or TolB, illustrating the flexible nature of TolA as a
periplasmic hub protein.
The Tol-Pal4 network of proteins in the periplasm of Gram-
negative bacteria is intriguing as conservation of the sequence
of genes of the tol-pal operon across a variety of bacterial orders
(1) suggests important functional significance of the Tol pro-
teins. Although their normal cellular function in Escherichia
coli is still uncertain (1), they appear to play a role in maintain-
ing the integrity of the cell envelope, transducing energy from
the cytoplasmic membrane, and may form a dynamic subcom-
plex at constriction sites to promote the energy-dependent sep-
tal wall formation across invaginating peptidoglycan and inner
membrane layers during cell division (2–4). The Tol-Pal sys-
tem consists of five proteins, TolA, TolB, TolQ, TolR, and pep-
tidoglycan-associated lipoprotein (Pal). TolA is a 44-kDa
periplasmic protein organized into three domains separated by
clusters of glycine residues. It is anchored to the cytoplasmic
membrane via a single transmembrane region (TolAI)5 that is
important for interactions with the TolQ and TolR proteins in
the membrane (5), spans the periplasm via its extended central
domain (TolAII), and binds to bothTolB (6, 7) and Pal (8) via its
C-terminal domain (TolAIII). TolQ and TolR are transmem-
brane proteins that are involved in the proton motif force-de-
pendent activation of TolA (2), which shuttles energy from the
inner to outer membrane through its association with Pal
anchored to the outer membrane (9, 10). TolB is a periplasmic
protein that is associatedwith the outermembrane via an inter-
action of its C-terminal -propeller domain with Pal (11) and
with TolA via its N-terminal domain (6).
ColA is a pore-forming colicin that forms pores in the cyto-
plasmicmembrane of E. coli cells (12). The N-terminal translo-
cation domain of ColA contains a binding region from residues
52–97 that interacts directly with TolAIII (13, 14). A TolA
binding motif with a conserved tyrosine residue has been iden-
tified at two locations (57SYNT60 and 89PYGR92) within the
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TolAbox region ofColAwith goodhomology to aTolAbinding
motif in the C-terminal domain of Pal (15). TolA is also
required for the entry of ColN (16) and for the import of fila-
mentous bacteriophage DNA into E. coli cells (17) through an
interaction with the gene 3 protein of bacteriophage fd (g3p),
which is a minor coat protein located at the end of the phage
capsid (18).
Protein-protein interactions are crucial for the translocation
of colicin domains into target cells, but the temporal and spatial
relationships between Tol proteins and colicin domains are
only just starting to be elucidated (19, 20). X-ray structures of
members of the Tol-Pal assembly in complex with partner pro-
teins have provided valuable information in deciphering the
sequence of events that occur when group A colicins parasitize
a sensitive cell (21–24). A solution structure of TolAIII (Protein
Data Bank (PDB) ID: 1S62) (25) and an x-ray structure of a
fusion formed from TolAIII and g3p (PDB ID: 1Tol) (26) have
been reported, but despite its pivotal role in the Tol assembly of
proteins and availability for binding to foreign polypeptides, a
structure of TolAIII in complex with other Tol proteins or with
colicin domains has not previously been reported. The present
work aims to address the role of TolAIII in the uptake of ColA
through determination of the x-ray crystal structures of E. coli
TolAIII on its own and in complex with the TolA binding
region of ColA.
EXPERIMENTAL PROCEDURES
Overexpression and Purification—E. coli B834(DE3) was
used as an expression host for plasmids pYZ48 (residues 302–
421 of TolA (TolAIII) cloned into pET21a via NdeI/XhoI
restriction sites with an in-frame N-terminal His6 tag) or
pYZ69 (27) to purifyTolAIII andTA1–107 6 containing a throm-
bin recognition site after residue 52, respectively. An overnight
culture of 10 ml of Luria Bertani medium (LB) was used to
inoculate 0.5 liter of 2YTbroth supplementedwith ampicillin
(Melford Laboratories) to a final concentration of 100 g/ml.
Cultureswere shaken in 2-liter baffled flasks at 180 rpmat 37 °C
until they reached an A600 of 0.6–0.8; protein expression was
induced for a period of 4 h after adding isopropyl--D-thio-
galactopyranoside to a final concentration of 1 mM. For sel-
enomethionine-labeled protein expression, E. coli 834 (DE3)
harboring pYZ48 or pYZ69 was used as the expression host.
The pellet from a 5-ml overnight culture grown in LB supple-
mented with ampicillin and chloramphenicol (34 g/ml) was
resuspended in 5 ml of sterile 0.9% NaCl and incubated in a
shaker at 37 °C for 30 min, and the cells were spun down and
washed again with 5 ml of sterile 0.9% NaCl before the pellet
was transferred into 100ml of Selenomethioninemediumcom-
plete (Molecular Dimensions Ltd.) containing L-methionine
and grown overnight at 37 °C. The overnight culture was
washed twice in 0.9% sterile NaCl as described previously, and
the pellet was transferred into 500 ml of selenomethionine
medium complete containing L-selenomethionine before pro-
tein induction was carried out for 4 h at 37 °C with 1 mM iso-
propyl--D-thiogalactopyranoside when the cell A600 reached
0.6–0.8.
Once resuspended in a buffer containing 50 mM Tris-HCl,
pH 8.0, 300 mM NaCl, 10 mM imidazole (lysis buffer), the cell
pellets were lysed by sonication, and the lysate was centrifuged
at 27,000  g for 30 min. The supernatant was filtered into
nickel-agarose beads (nickel-nitrilotriacetic acid, Qiagen),
which were previously equilibrated with lysis buffer and gently
mixed by circular rotation in a cold room for 1 h. The beads
were washed with 50 mM Tris-HCl, pH 8.0, 300 mM NaCl,
10–30 mM imidazole (wash buffer), and finally, the proteins
were eluted with 50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 250
mM imidazole (elution buffer).
A region of TA1–107 containing a TolA binding site (TA53–107)
was separated from the TolB box by digestion of TA1–107
with thrombin at a thrombin recognition site engineered into
TA1–107 after residue 52. The protein concentration was
adjusted to 1 mg/ml in 20 mM Tris, pH 8.0, 100 mM NaCl con-
taining 5 units/mg of thrombin (Haematologic Technologies
Inc., Essex Junction, VT), and the mixture was left on a circu-
lating platform rotor at room temperature overnight. The
thrombin was then removed using -aminobenzamidine-aga-
rose beads (Sigma) according to the manufacturer’s instruc-
tions, and TA53–107 was purified using metal chelate chroma-
tography and nickel-agarose beads in His tag lysis buffer as
described previously (27). TA53–107 was finally loaded to a
Superdex 75 gel filtration column (GE Healthcare) to remove
any undigested TA1–107. The purity of protein samples was
checked by running 15–17% SDS-PAGE gels. Pure fractions of
TA53–107 were combined, concentrated using 5-kDamolecular
mass cut off concentrators (Vivascience), anddialyzed to 20mM
Tris, pH 8.0, 100 mM NaCl. Protein concentration was deter-
mined by using absorption at 280 nm and extinction coeffi-
cients of 15,470, 8480, and 6085 M1cm1 for TA1–107 with a
thrombin cleavage site after residue 52, TA53–107, and TolAIII,
respectively.
NMR Spectroscopy—Isotopically labeled TolAIII comprising
amino acids 302–421 of the E. coli TolA protein (Swiss-Prot
accession number P19934) and TA1–52 and TA53–107 contain-
ing theTolB box andTolA binding region of ColA, respectively,
were prepared as described previously (27). The B1–13 peptide
representing the N-terminal sequence of TolB lacking its signal
peptide and comprising residues 21–33 of TolB (AEVRIVIDS-
GVDS) was purchased fromUnited Peptide Corp. at a purity of
95%. NMR spectra were acquired at the indicated temperatures
using a Bruker Avance III 800-MHz spectrometer equipped
with a triple resonance probe and pulse sequences incorporated
into the Bruker Topspin 2.1 software. Resonance assignments
of 13C/15N-labeledTA53–107 in complexwith unlabeledTolAIII
(1.2 mM) were obtained from 1H-15N HSQC, CBCA(CO)NH,
HNCACB, andHNCA spectra at 27 °C. NMR spectra were pro-
cessed using NMRPipe (28) and analyzed in NMRView and
CCPN-Analysis as described previously (29).
Formation and Methylation of TA53–107-TolAIII Complex—
TA53–107 and TolAIII in 20 mM Tris, pH 8.0, and 100 mMNaCl
were mixed in a 1.1:1 molar ratio and incubated at 4 °C over-
night. The mixed sample was loaded onto a Superdex 75 col-
6 The following designations are used for residues throughout this manu-
script: TA53–107, residues 53–107 of the translocation domain of colicin A;
TA1–107, residues 1–107 of the translocation domain of colicin A; TA1–52,
residues 1–52 of the translocation domain of colicin A.
Binding Sites of E. coli TolA Hub Protein
JUNE 1, 2012•VOLUME 287•NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 19049
 at U
N
IV
 O
F N
O
TTIN
G
H
A
M
 on M
arch 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
umn equilibrated with 20 mM Tris, pH 8.0, 100 mM NaCl and
run at a flow rate of 1 ml/min on an FPLC system (ÄKTA). The
elution fractions were checked by running on 17% SDS-PAGE
gels. The methylation of the TolAIII-TA53–107 complex was
carried out using a published protocol (30, 31). Briefly, both
TA53–107 and TolAIII were exchanged into 50 mM Hepes, pH
7.5, 100 mM NaCl and were mixed in a 1.1:1 molar ratio. Then
the complex was adjusted to 1 mg/ml or 0.5 mg/ml for meth-
ylation of the selenomethionine-labeled complex. Methylation
was carried out by adding borane dimethylamine complex
(Sigma), which is a reducing agent, followed by formaldehyde
(Sigma) before an overnight incubation at 4 °C (30, 31). The
reaction was quenched by adding Tris buffer, pH 8, to 20 mM,
and then the product was concentrated and buffer-exchanged
into 20mMTris, pH 8, 100mMNaCl for gel filtration to remove
the small reactants and excess TA53–107.
Crystallization, X-ray Diffraction, and Model Refinement—
The methylated TA53–107-TolAIII complex was crystallized by
using the sitting-drop vapor diffusionmethod at 20 °Cwith 2l
of the complex at 35mg/ml in 20mMTris-HCl, pH 8.0, 100mM
NaCl mixed in equal volumes with the reservoir solution con-
taining 0.2 M K2HPO4, 2.2 M ammonium sulfate. The complex
crystals grew after 3–4weeks. Before being frozen in a nitrogen
stream, crystals were soaked in 0.2 M KH2PO4, 2.26 M ammo-
nium sulfate, and 1.1 M disodium malonate for cryoprotection.
Diffraction data sets were collected at the European Synchro-
tron Radiation Facility (ESRF), Grenoble, France, using a MAR
225 detector at amicrofocus beamline of ID23-2 ( 0.8726Å)
for native crystals and an ADSC Quantum Q315r detector at a
beamline of ID14-4 (  0.9795 Å) for selenomethionine-la-
beled crystals. A wavelength of 0.9795 Åwas used for collecting
the single anomalous dispersion data sets for selenomethio-
nine-labeled crystals. After failure to get the phase frommolec-
ular replacement using the available TolAIII structures PDB ID
1Tol (26) and PDB ID 1S62 (25) as search models, selenome-
thionine-labeled crystals of this complex were used to obtain
the phase.
All data were processed with XDS (32), converted from XDS
format to mtz format with Pointless (33), and scaled in SCALA
(34) of the CCP4 suite (35). The initial phasewas determined by
using Phaser-EP (36) with the coordinates of four anomalous
atoms found by Solve (37). The phase was improved by running
the Density Modification (DM) program (38) and extended
from 2.8 Å of selenomethionine crystals to 2.65 Å of native
crystals using Cad and Scaleit of the CCP4 suite. The initial
model was built by using Buccaneer (39) with 100 cycles and
COOT (40), and then themodel was used as a searchmodel for
molecular replacement through the use of Phaser (36) against
the native data, rebuilt in COOT, and refined using restrained
and TLS refinement in REFMAC5 (41). The optimal number of
TLS groups was determined using the TLSMD server (42). The
final model has excellent geometry and no Ramachandran out-
liers. The data processing, phasing, and model refinement sta-
tistics are summarized in Table 1. Surface area accessibility cal-
culations and cation- interaction identifications were carried
out using the programs AREAIMOL (43) and CaPTURE (44),
respectively. All structural figures were prepared using PyMOL
(67).
Colicin Activity Assay—Spot test assays of biological activity
of ColA and ColA mutants were conducted as described previ-
ously (45).
PCR Mutagenesis—Point mutations of the ColA gene were
generated using the QuikChange II site-directed mutagenesis
kit (Stratagene) according to the manufacturer’s instructions.
All constructs were verified by DNA sequencing (Source Bio-
Science, Nottingham, UK).
Surface Plasmon Resonance—Surface plasmon resonance
assays were conducted as described previously (24). TolAIII
was immobilized to the matrix of a newly docked CM5 sensor
chip, pre-equilibrated inHBS-EP running buffer (10mMHepes,
150 mM NaCl, 3 mM EDTA, 0.005% Tween) (BIAcore AB) via
amine coupling to a level of immobilization of 200 response
units. Two-minute injections of 10 M of the ColA and ColA
mutant proteins were performed across the immobilized
TolAIII on the CM5 chip at a flow rate of 30l/min. After each
analyte injection, the sensor chip surface was regenerated using
a 2-min pulse of 10 mM glycine, pH 1.8. Global analysis using
BIAevaluation software 3.1 was used to align all the binding
curves. To determine the binding affinity data, 2-min injections
of a range of concentrations of TA1–107 or TA53–107 were per-
formed using the same TolAIII chip. Global analysis using
BIAevaluation software 3.1 was used to fit corrected surface
plasmon resonance responses to the theoretical 1:1 Langmuir
binding model.
RESULTS
Crystallization of TA53–107-TolAIII Complex—Initially, we
were unable to obtain crystals of TolAIII in complex with a
polypeptide of ColA expressing residues 1–107 (TA1–107). Dis-
order analysis of the sequence of TA1–107, using the RONN
program (46), showed that the N terminus of ColA containing
the TolB box (residues 11–20) is disordered (47–49), whereas a
region containing residues 52–97, predicted to contain the
TolAIII binding region of ColA (50), was ordered (supplemen-
tal Fig. S1). The TA53–107 polypeptide produced from the
thrombin cleavage of TA1–107 (see “Experimental Procedures”)
and lacking theTolB boxwas able to forma stable complexwith
TolAIII with a binding affinity of 1.34  0.008 M (data not
shown). However, only tiny protein crystals grew from crystal-
lization screens of the TA53–107-TolAIII complex. High
entropy residue analysis of TolAIII was performed by using a
surface entropy reduction prediction server (51), which pre-
dicted five high entropy surface lysine residues in four clusters
(supplemental Fig. S2). The reductive methylation of lysine resi-
dues has previously been reported to be a valuable rescue strategy
for obtaining diffraction-quality crystals from proteins found
previously difficult to crystallize (30). Crystals of a complex of
selenomethionine-labeled TolAIII and TA53–107 proteins, which
wasmethylatedbefore crystallization, appeared in theorthorhom-
bic space group P21212, with one TolAIII and one TA53–107 poly-
peptide in the asymmetric unit and a solvent content of 58%.
Crystal Structure of TA53–107-TolAIII Complex—The struc-
ture consists of residues 329–421 of TolAIII and residues
57–105 of TA53–107, 26 water molecules, and one Tris ion (Fig.
1). Only Lys-351 of TolAIII was methylated in the TA53–107-
TolAIII complex. The structure was refined to a resolution of
Binding Sites of E. coli TolA Hub Protein
19050 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 23•JUNE 1, 2012
 at U
N
IV
 O
F N
O
TTIN
G
H
A
M
 on M
arch 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
2.65 Å with the Rfactor and Rfree being 24.4 and 27.3%, respec-
tively (Table 1). The structure of TolAIII consists of three
-helices and three -strands with a short helix between the
first-helix and the first-strand. There are two small-sheets
in TA53–107 located in its C and N terminus, respectively, each
composed of two -strands connected by a hairpin. Thus the
structure of TA53–107 is like a skipping rope with two small
-sheets at the C terminus and N terminus acting as the two
handgrips of the rope. The N-terminal -sheet forms four
intramolecular hydrogen bonds, whereas the C-terminal
-sheet forms eight, all of them formed between the backbone
atoms. The -sheet at the C terminus of TA53–107 forms an
intermolecular antiparallel -sheet with the three -strands of
TolAIII. The remainder of TA53–107, mainly between the two
small -sheets, forms a hairpin and loops. Therefore, the com-
plex forms a five -strand sheet, with the -helices of TolAIII
on one side and theN-terminal small-sheet, together with the
hairpin and loops of TolA box, on the other side of the five
-strand sheet of the complex (Fig. 1). There are no similar
structures to that of TA53–107 available in the PDB database
from search results using the Dali server.
Binding Interface between TA53–107 and TolAIII—The bind-
ing interface between TA53–107 and TolAIII buries a total sur-
face area of 1303 Åwith TolAIII and TA53–107 contributing 683
and 620 Å, respectively. The buried surface area is in the range
of 1200–2000Å that has been observed formost heterodimeric
protein-protein complexes (52, 53). The calculated shape com-
plementarity index, (Sc) (54) is 0.72, which is higher than that of
high affinity protein-protein complexes such as the colicin E3
DNase-Im3 and colicin E9 DNase-Im9 complexes, indicating a
high level of complementarity betweenTolAIII andTA53–107 in
the complex. The interactions between TolAIII and TA53–107
encompass mainly electrostatic interactions and hydrophobic/
apolar contacts. There are six direct hydrogen bonds between
residues 92–96 of TA53–107 and residues 375–380 of TolAIII
with the two protruding side chains Arg-92 and Arg-96 from
FIGURE 1. Structure of TA53–107-TolAIII complex.A stereo image of the sec-
ondary structure of TA53–107 (cyan) in complex with TolAIII (green) displaying
a classical -sheet augmentation pattern of complex formation is shown.
FIGURE 2. Binding interface of TA53–107-TolAIII complex. A ball and stick
representation of the interface between TA53–107 (pink) and TolAIII (green) is
shown. Intermolecular hydrogen bonds either direct or mediated by a water
molecule (gray sphere), between interacting residues are shown as hyphen-
ated lines.
TABLE 1
Data collection and refinement statistics
TolAIII
TA53–107-TolAIII
Native Se-Met
Data collection
Space group P31 2 1 P21 21 2 P21 21 2
Cell dimensions a, b, c (Å) 70.28, 70.28, 53.82 47.50, 119.62, 30.15 47.10,118.69, 29.85
Wavelength, Å 0.9792 0.8726 0.9795
Resolution range, Å 40.32–2.15 (2.27–2.15) 44.14–2.65 (2.79–2.65) 43.81–2.8 (2.95–2.8)
No. of unique reflections 8641 (1234) 5238 (757) 4356 (585)
Total no. of observations 84,194 (12,226) 18,767 (2757) 50,579 (3176)
Redundancy 9.7 (9.9) 3.6 (3.6) 11.6 (5.4)
Mean I/(I) 25.7 (5.0) 10.5 (3.8) 21.9 (5.7)
Completeness, % 100 (100) 97.4 (98.2) 97.3 (92.4)
Rmerge, % 5.6 (43.3) 9.8 (34.4) 9.1 (30.4)
Anomalous completeness, % 96.5 (87.2)
Anomalous redundancy 6.5 (3.0)
Phasing statistics
FOMa after PHASER 0.335
FOM after DM 0.528
FOM after Refmac5 0.797
Refinement statistics
Resolution range, Å 60.87–2.15 59.81–2.65
Rwork/Rfree % 19.2/22.5 24.4/27.3
r.m.s. bond lengths, Å 0.0286 0.0137
r.m.s. angles, ° 2.371 1.867
Average B-factor (protein, Å2) 20.3 26.4
No. of protein atoms 685 1059
No. of water and ion atoms 52 34
PDB accession code 3QDP 3QDR
a FOM, figure of merit.
Binding Sites of E. coli TolA Hub Protein
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TA53–107 forming hydrogen bonds with Pro-380 and Leu-375
of TolAIII (Fig. 2, supplemental Table S1). A water molecule
mediates three hydrogen bonds between Phe-94 of TA53–107
and Asp-377 of TolAIII. The crystal structure of the TA53–107-
TolAIII complex indicates that the minimum size of the
TolAIII binding region of ColA consists of residues 58–96,
rather than the previously described residues 52–97 (50), which
is still larger than the TolAIII binding region of colicin N (55).
Mutational Analysis of Interface Residues of TA53–107-
TolAIII Complex—Alanine-scanning mutagenesis of the five
interface residues of ColA (Arg-92–Arg-96) that interact with
TolAIII was performed, and the biological activity of the puri-
fied mutant proteins was assessed using a colicin plate assay
(Fig. 3). Alanine mutations of any one of the five interface resi-
dues of ColA had little effect on biological activity, as can be
seen for the F94Amutant of ColA in YZ106 (Fig. 3). The intro-
duction of multiple alanine mutations of the interface residues
revealed an additive effect that was observed as a reduction in
biological activity of themutant ColA. The presence of both the
F94A and the R96A mutations (in YZ108) resulted in a further
small reduction of biological activity when compared with
YZ106 (Fig. 3). The further addition of a T95A mutation (in
YZ109) resulted in a major reduction of biological activity. A
complete loss of biological activity was seen with YZ110, in
which all five of the interface residues were mutated to alanine.
In parallel, the contribution of the five residues of TolAIII to
the binding interface of the TolAIII-TA53–107 complex was also
determined. Mutations were engineered into pTol, which
expresses the TolA protein (56), and assayed for activity by
complementation of the tolAmutant, E. coli JC7782. Individual
alanine mutations of residues Leu-375, Leu-376, Asp-377, Ile-
378, and Pro-380 of TolAIII were still able to complement the
tolAmutant, resulting in the restoration of sensitivity to ColA,
whereas a mutant containing alanine substitutions in all five
residues that contribute to intermolecular contacts across the
interface did not complement the tolA mutant (Table 2). Sur-
prisingly, mutants of pTol containing alanine substitutions of
Leu-376, Asp-377, and Pro-380 of TolAIII were still able to
complement the E. coli tolA mutant, albeit at reduced levels
(Table 2), despite the apparent loss of several important inter-
molecular polar contacts, particularly those contacts resulting
from the side chain of Asp-377 (Fig. 2).
NMR and X-ray Structural Comparisons of TolAIII and
TA53–107-TolAIII—The x-ray structure of free TolAIII was
obtained by chance in the process of the attempted crystalliza-
tion of the complex formed between TolAIII and a peptide rep-
resenting the N-terminal region of TolB lacking its signal pep-
tide (referred to here as B1–13). The complex was methylated,
but the structure was solved with only TolAIII in the density
without any extra density for B1–13.Mass spectrometry analysis
of the solubilized crystals proved that no peptide was present in
the crystallized sample. Therefore, the structure we have
obtained is that of TolAIII on its own.
The free TolAIII structure was refined to a resolution of 2.15
Å with Rfactor and Rfree being 19.2 and 22.5%, respectively. The
first 32 residues have no corresponding electron density and are
omitted in the model. Only three lysine residues (Lys-345, Lys-
351, and Lys-413) were identified as being methylated, with
lysines 345 and 413 being dimethylated and Lys-351 being
monomethylated (supplemental Fig. S3). In addition, there are
two nitrate ions and 43 water molecules in the model. The free
x-ray structure has amarked similarity to theNMR structure of
TolAIII (PDB ID: 1S62) (25) with three -helices and three
-strands (supplemental Fig. S4). However, subtle differences
exist that prevented our determination of the x-ray structure of
free TolAIII bymolecular replacement using PDB IDs 1S62 and
1Tol as search models, suggesting that there are some confor-
mational differences between our free x-ray TolAIII structure
and both the NMR solution structure of TolAIII and the x-ray
FIGURE 3. Effects of TolA box mutations of ColA on activity of ColA are
cumulative. A, individual (pYZ106), double (pYZ107 and pYZ108), and mul-
tiple mutations of the TolA box of ColA (pYZ109 and pYZ110) were engi-
neered using PCR mutagenesis, and the mutant polypeptides were purified
and spottedonto a lawnof sensitive E. coli cells. B, zones of clearing indicative
of cell killing were reduced in mutants containing successively more muta-
tions and disappeared in all mutants containing three or more mutations.
TABLE 2
Complementation of the TolA mutant strain of E. coli, JC7782 with
TolA and TolA containing various mutations expressed from the plas-
mid, pTol
Strain TolAIII mutation Complementationa
JC7782 TolA 250 nMb
JC7782 (pTolA) None 10 nM
JC7782 (pST1) L375A 10 nM
JC7782 (pST2) L376A 50 nM
JC7782 (pST3) D377A 10 nM
JC7782 (pST4) I378A 10 nM
JC7782 (pST5) P380A 10 nM
JC7782 (pNP341) L375A, D377A, P380A 50 nM
JC7782 (pNP342) L375A, L376A, D377A,
I378A, P380A
250 nMb
a Complementation was assessed as the lowest concentration of colicin A that was
able to produce a visible zone of inhibition on LB agar plates containing an over-
lay of the strain indicated in the table.
b Zones of inhibition were not seen in these strains at any concentration of ColA
tested.
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structure of TolAIII fused with g3p. Our TolAIII structure was
solved bymolecular replacement using the structure of TolAIII
from the TA53–107-TolAIII complex as a search model. This is
consistent with comparisons of the root mean square distance
(r.m.s.d.) of the C atoms of the free TolAIII x-ray structure
with otherTolAIII structures; the r.m.s.d. values are 2.08, 1.549,
1.673, and 0.537 when compared with PDB IDs 1LRO, 1S62,
1Tol, and 3QDR (TolAIII in complex with TA53–107), respec-
tively. Helix II runs from residues 385–370 in PDB ID 1S62 and
from residues 390–370 in PDB ID 3QDP, whereas Helix III is
the same in both structures and includes residues 410–413
(supplemental Fig. S4). Helix I is shorter in PDB ID 3QDP and
might be a consequence of the methylation of Lys-345 (supple-
mental Fig. S3). However, in silico mutagenesis of Lys-345 to
Ala did not produce any extra helicity to Helix I. -Strands 1
and 2 in PDB ID 1S62 are linked by a short hairpin and are
longer than their counterparts in PDB ID 3QDP, whereas three
shorter-strands in PDB ID 3QDP form an antiparallel-sheet
(supplemental Fig. S4). The partially ordered segment that con-
nects helix I and -strand 1 shows differences between the two
structures with C atoms r.m.s.d. of 1.83 Å.
Cation- Interactions in TA53–107-TolAIII Complex—Geo-
metrical analysis for cation- interactions in the interface of the
complex shows that three putative cation-aromatic contacts
have suitable geometry. TheNZ atoms of Lys-368, Lys-379, and
Lys-396 of TolAIII, none of which are methylated, align above
the aromatic rings of Tyr-58, Tyr-90, and Phe-94 of TA53–107,
respectively (Fig. 4, supplemental Table S1). The cation-
interactions were analyzed by using the CaPTURE server (44),
which predicted that the three pairs of Tyr-58–Lys-368, Tyr-
90–Lys-379, and Phe-94–Lys-396 were energetically signifi-
cant with electrostatic energies of 3.62, 3.32, and 2.78
kcal/mol, respectively. These three cation- interactions are
located on the two sides of the -sheet in the complex. The
hydrophobic/apolar contacts mainly involve the side chains of
Met-87 and Phe-94 from TA53–107 and Leu-375, Ile-378, Leu-
392, and Lys-396 from TolAIII that form a hydrophobic patch
between the -sheet and the second -helix.
Superposition of TolAIII in complex with the TolAIII bind-
ing region of ColA and the solution structure of TolAIII (PDB
ID: 1S62) reveals some side chain rearrangements at the inter-
face with TA53–107 (Fig. 5). A significant rearrangement occurs
from the movement of the side chain of Lys-396 of TolAIII,
which makes space for the side chain of Met-87 and positions
the side chain of Lys-396 directly over the aromatic ring of
Phe-94, thus forming a cation- interaction between both res-
idues (Fig. 5). Less dramatic rearrangements of the side chains
of Lys-379 and Lys-368 result in the juxtaposition of each resi-
due with Tyr-90 and Tyr-58, respectively, allowing the forma-
tion of two further cation- interactions across the binding
interface. Interestingly, the relocation of the side chain of Asp-
377 of TolAIII toward TA53–107 leads to the breakage of a salt
bridge between Asp-377 and Lys-368 (observed in the free
TolAIII structure) and establishment of a hydrogen bond
between Asp-377 and Thr-95. In addition, the side chain of
Leu-376 of TolAIII moves away from the TolA binding region,
liberating Tyr-58 for the cation- interaction with Lys-368
(Figs. 4 and 5).
The significance of the three cation- interactions on the
formation of theTA53–107-TolAIII complexwas investigated by
engineering the mutations Y58A, Y90A, and F94A in the TolA
box of ColA and assessing the impact of these substitutions on
both binding and biological activity. Comparison by surface
plasmon resonance showed that TA1–107 Y90A and TA1–107
F94A had almost identical binding affinities with TolAIII as
TA1–107, whereas no interaction of TolAIII was detected with
TA1–107 Y58A, indicating an important role for Tyr-58 in sta-
FIGURE4.Cation- interactionsacrossTA53–107-TolAIII complex.Electron-
rich aromatic tyrosine (Tyr-58, Tyr-90) and phenylalanine (Phe-94) residues of
the TolA box stack perpendicular to the positively charged side chains of
lysine residues (Lys-368, Lys-379, Lys-396), forming cation- interactions that
strengthen and stabilize the interaction at the interface between the two
polypeptides.
FIGURE 5. Conformational changes to lysine residues of TolAIII on bind-
ingTA53–107. Lysine residues, Lys-368 and Lys-396, are shifted onbinding the
TolA box of ColA and realign with the aromatic residues Tyr-58 and Phe-94,
respectively, forming stabilizing cation- interactions. Residues Leu-376 and
Asp-377 are favorably shifted to accommodate the formation of the two cat-
ion- interactions. Asp-377 forms a hydrogen bond (dashed line) with Thr-96
across the binding interface of the two polypeptides. Arrows indicate the size
and direction of the conformational shifts.
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bilizing the interaction of TA53–107 with TolAIII (supplemental
Fig. S5A). Consistent with these binding data, Y90A and F94A
had no effect on the biological activity of ColA, whereas Y58A
had significantly reduced activity when compared with wild-
type ColA (Fig. 3; supplemental Fig. S5B).
DISCUSSION
This work describes the first crystal structure of TolA in
complex with a colicin translocation domain and also reveals
for the first time the interaction of a Tol protein with a globular
colicin domain. The interface of the complex of TolAIII with
the TA53–107 region of ColA comprises polar interactions
involving residues within -strands of each protein, further
augmented by intermolecular cation- interactions. The
-strand residues involved in contact across the interface align
in an antiparallel fashion, and those from both the TA53–107
protein (92–96) and TolA (375–380) exhibit a significant
degree of surface exposure. The average relative solvent acces-
sibilities for all side chain atoms of these residues, calculated
using Naccess (68), are 64 and 46%, respectively. An
exhaustive search of the PDB allowed Remaut and Waksman
(57) to classify protein-protein and protein-peptide complexes
involving the association of a -strand from a ligand with a
-strand or a -sheet in a binding partner into three distinct
classes: (i) -sheet augmentation, (ii) -strand insertion and
fold complementation, or (iii) -strand zippering. The protein-
protein interface described by the x-ray structure here would
appear to represent the classical -sheet augmentation where
the interaction ismediated by a-strand fromone protein pair-
ing to the edge of a -sheet in the binding domain of another
protein (Fig. 1).
Although methylation was essential to obtain our x-ray
structures of TolAIII and the TA53–107-TolAIII complex, we do
not believe that methylation itself introduced any significant
differences that affected the interpretation of the results. Our
evidence for this is partly because of the observed similarity in
the 1H-15N HSQC NMR spectra of the complex of 15N-labeled
TA53–107 bound to unlabeled TolAIII with and without
N-methylation (supplemental Fig. S6) and the fact that different
patterns of methylation were observed in both free and com-
plexed TolAIII. Although differences do exist between the
structures of TolAIII determined by x-ray (herein) and NMR
methods (25), they are small, and the residues predicted to be
important in the interaction of TolAIII with TA53–107 by NMR
(27) are identical to those residues shown to be involved in the
x-ray structure of the TA53–107-TolAIII complex (Fig. 2). The
x-ray data of TolAIII alone or in complexwithTA53–107 are also
identical apart from the conformational changes exerted by
interacting residues across the interface of the two proteins
(Fig. 5).
The contribution of individual residues of both TolAIII and
TA53–107 to the binding interface of the TA53–107-TolAIII com-
plex was determined by alanine-scanning mutagenesis. No
mutation of a single residue at the interface in either TA53–107
or TolAIII prevented the interaction with the partner protein
(Fig. 3; Table 2). This is very different from the interaction
observed for theTolB box ofColA andTolBwherebymutations
to individual residues that contribute intramolecular bonds to
the fold of the TolB box on binding TolB abolish the interaction
with TolB (24, 45). As the hydrogen bonds between residues
Phe-94 and Thr-95 of TA53–107 and Leu-375, Leu-376, and Ile-
378 of TolAIII occur from backbone atoms, this mutagenesis
result is perhaps unsurprising (Fig. 2). However, the hydrogen
bonds between residues Arg-92 and Arg-96 of TA53–107 are
from side chain atoms specific to each arginine residue, which
might be expected to be essential for the formation of the inter-
action between the two polypeptides. However, no significant
loss of activity of ColA was observed when themutations R92A
and R96A were engineered into ColA simultaneously (Fig. 3).
This is the first reported example of a colicin-ligand interac-
tion in which cation- interactions contribute to the interact-
ing complex. The importance of each cation- interaction was
initially assessed from the x-ray structure (Fig. 4; PDB ID:
3QDR). Tyr-58–Lys-368 has much closer, better coordinated
dipoles than the other two paired residues and would perhaps
be expected to contribute stronger electrostatic interactions.
Mutagenesis of all three aromatic residues of the TolA binding
region that are involved in cation- interactions, and analysis of
the interaction of the mutated polypeptides with TolA by bio-
logical activity assays and surface plasmon resonance, con-
firmed that Tyr-58 was essential for complex formation,
whereas Tyr-90 and Phe-94 were not essential (supplemental
Fig. S5, Fig. 3). Pommier et al. (15) had previously identified
Tyr-58 and Tyr-90 within two putative TolA binding regions of
ColA. Cation- interactions have been shown to be vital in the
translocation of lethal factor through the protective antigen
channel of the anthrax toxin by establishing a protein-protein
tether that encourages unidirectional movement of the toxin
into the cytosol of endocytosed cells by a Brownian ratchet
motion (58).
ColA is unique in colicin biology in possessing different bind-
ing epitopes for two Tol proteins. A detailed model for the
recruitment of TolB by the TolB box of ColE9 has been pre-
sented (59, 60). Such models have to be extended to explain
the translocation of ColA to accommodate the additional inter-
action of the TolA binding site with TolA. It has been proposed
that the translocation domain of ColA interacts firstly with
TolB in the periplasm, via a low affinity interaction of its TolB
box, and thenwith TolA via a higher affinity interactionwith its
TolA binding site (24). The structural and mutagenesis infor-
mation in this study provides more detail of the latter
interaction.
Filamentous phages infect E. coli in a two-step process that
involves the interaction of two N-terminal domains of the g3p
protein of phage fd (N2 and N1) that bind to cell pili and
TolAIII, respectively, in a sequential manner (26). In the fully
folded form of g3p, the N1 and N2 domains are tightly associ-
ated and without disassociation of both domains by the bind-
ing of N2 to the cell pilus, N1 is unable to interact with TolAIII,
and the virus is noninfective. However, the structure of the
TA53–107-TolAIII complex reveals that the TolA binding
region ofColAbinds to a different region ofTolAIII than that to
which g3p binds (26), with no single residue of TolAIII being
involved in binding to both proteins (Figs. 6 and 7).
There is currently no published evidence to suggest that the
TolA binding site and the TolB box of ColA interact with each
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other in a similar way to the N1 and N2 domains of g3p. How-
ever, we have preliminaryNMRdata showing that the chemical
shifts of a mixture of the TA1–52 and TA53–107 peptides were
slightly different for some residues of TA53–107 when compared
with those of TA53–107 on its own.7 NMR data have shown
that a truncated polypeptide expressing both the TolA binding
region and the TolB box of ColA causes an unfolding of TolAIII
in vitro, which is not apparent when the TolA binding region
and TolB boxes are physically separated and added to TolAIII
concurrently (27). If TolA binds TolB and ColA at different
binding interfaces in theTA1–107-TolA-TolB trimeric complex,
then it is possible that an unoccupied TolB box of ColA could
interfere and cause localized unfolding of TolAIII in the
TA1–107-TolAIII complex as unfolding of TolAIII is not
observed on binding of the translocation domain of ColN,
which does not possess a TolB box (27). Interestingly, the TolA
binding region of ColN forms intramolecular contacts with
globular regions of the protein as a means of enhanced protec-
tion against proteolytic cleavage rather than domain inactiva-
tion, as seen with phage fd (29).
The binding interface of the TolA binding region of ColA
presented here shows a unique fold that binds on the opposite
side of TolAIII to a conserved hydrophobic cavity that forms
the interfacewith the g3p protein (26), which has been reported
as influential for conformational changes of TolAIII important
for interactingwith different binding partners inE. coli (25) and
Pseudomonas aeruginosa (61). Recent NMR data on the inter-
action of TolAIII with ColN have also predicted a similar bind-
ing interface to that of g3p-TolAIII, but the precise details of the
interaction of ColN with the hydrophobic cavity of TolAIII
have not yet been elucidated.7 It has recently been demon-
strated that TolA interacts with TolB as a prerequisite to the
translocation of the enzymatic colicin, ColE9 (60). The interac-
tion is believed to involve the extreme N terminus of TolB,
but the interacting region of TolA is currently unknown. How-
ever, the similarity of the 1H-15N HSQC NMR spectrum of
TolAIII in the B1–13-TolAIII complex (supplemental Fig. S7)
with that of ColN-TolAIII (29) suggests that B1–13 binds
TolAIII in a similar manner to ColN and g3p. TolA has also
been predicted to interact with ColE1 differently than other
group A colicins (62) and with YbgF via TolAII (63), and there-
fore, TolA exhibits the properties of a promiscuous hub protein
that interacts with both intrinsic and extrinsic proteins through
several different interaction sites (64). Apart from interacting
networks involved in peptidoglycan synthesis and cell envelope
biogenesis (65), the only other well characterized set of inter-
acting periplasmic proteins consists of those linked by the hub
protein NDsbD that are involved in disulfide isomerization
(66). Several colicins and bacteriophages have taken advantage
of the promiscuity afforded them by TolA for unimpeded entry
into an E. coli cell. Elucidation of structural data on the interac-
tion of TolA with TolB will not only extend our understanding
of the pivotal role of TolA in cell function and homeostasis of
Gram-negative bacteria, but will enhance opportunities of
using TolA as a drug target for antimicrobial treatments.
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